N

NextBioMedical Co Ltd
KOSDAQ:389650

Watchlist Manager
NextBioMedical Co Ltd
KOSDAQ:389650
Watchlist
Price: 79 300 KRW -1.37% Market Closed
Market Cap: ₩650.3B

NextBioMedical Co Ltd
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

NextBioMedical Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
N
NextBioMedical Co Ltd
KOSDAQ:389650
Note Receivable
-₩300
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Note Receivable
₩2.8B
CAGR 3-Years
66%
CAGR 5-Years
16%
CAGR 10-Years
11%
C
Classys Inc
KOSDAQ:214150
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

NextBioMedical Co Ltd
Glance View

Market Cap
650.3B KRW
Industry
Health Care

NextBioMedical Co Ltd is a KR-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2024-08-20. NextBioMedical Co Ltd is a Korea-based company mainly engaged in the manufacturing and sales of medical equipment. The firm is mainly engaged in the manufacturing and sales of medical equipment, such as endoscopic hemostatic agents and vascular embolic microspheres. In addition, the Company is also engaged in the research and development of medical equipment.

Intrinsic Value
33 228.48 KRW
Overvaluation 58%
Intrinsic Value
Price
N

See Also

What is NextBioMedical Co Ltd's Note Receivable?
Note Receivable
-300 KRW

Based on the financial report for Dec 31, 2024, NextBioMedical Co Ltd's Note Receivable amounts to -300 KRW.

What is NextBioMedical Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 1Y
25%

Over the last year, the Note Receivable growth was 25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett